ScoreWhy is Haleos Labs Limited ?
1
Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 9.15%
- Poor long term growth as Net Sales has grown by an annual rate of 8.71% and Operating profit at 13.38% over the last 5 years
2
Positive results in Dec 25
- DEBT-EQUITY RATIO(HY) Lowest at 0.34 times
- OPERATING PROFIT TO INTEREST(Q) Highest at 9.12 times
- NET SALES(Q) Highest at Rs 94.78 cr
3
Stock is technically in a Bullish range
- The technical trend has improved from Mildly Bullish on 22-May-26 and has generated -3.34% returns since then
- Multiple factors for the stock are Bullish like MACD, Bollinger Band, KST, DOW and OBV
4
With ROCE of 11, it has a Attractive valuation with a 2.1 Enterprise value to Capital Employed
- The stock is trading at a discount compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 20.74%, its profits have fallen by -13.9%
5
Majority shareholders : Promoters
6
Market Beating performance in long term as well as near term
- Along with generating 20.74% returns in the last 1 year, the stock has outperformed BSE500 in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Haleos Labs Limi for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Haleos Labs Limi
29.29%
0.39
53.18%
Sensex
-1.65%
-0.49
12.94%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
2.46%
EBIT Growth (5y)
1.47%
EBIT to Interest (avg)
2.93
Debt to EBITDA (avg)
2.69
Net Debt to Equity (avg)
0.51
Sales to Capital Employed (avg)
1.24
Tax Ratio
29.42%
Dividend Payout Ratio
2.26%
Pledged Shares
0
Institutional Holding
0.31%
ROCE (avg)
8.76%
ROE (avg)
8.22%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
28
Industry P/E
37
Price to Book Value
2.08
EV to EBIT
22.06
EV to EBITDA
13.49
EV to Capital Employed
1.72
EV to Sales
1.70
PEG Ratio
NA
Dividend Yield
0.10%
ROCE (Latest)
8.71%
ROE (Latest)
8.11%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend0What is working for the Company
NO KEY POSITIVE TRIGGERS
-20What is not working for the Company
PBT LESS OI(Q)
At Rs 2.98 cr has Fallen at -50.50%
PAT(Q)
At Rs 2.65 cr has Fallen at -36.3%
NET SALES(Q)
Lowest at Rs 72.94 cr
INTEREST(Q)
Highest at Rs 1.90 cr
Loading Valuation Snapshot...
Here's what is not working for Haleos Labs Limi
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 2.98 cr has Fallen at -50.50%
Year on Year (YoY)MOJO Watch
Near term PBT trend is very negative
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
At Rs 2.65 cr has Fallen at -36.3%
Year on Year (YoY)MOJO Watch
Near term PAT trend is very negative
PAT (Rs Cr)
Net Sales - Quarterly
At Rs 72.94 cr has Fallen at -11.59%
Year on Year (YoY)MOJO Watch
Near term sales trend is very negative
Net Sales (Rs Cr)
Interest - Quarterly
At Rs 1.90 cr has Grown at 33.80%
Quarter on Quarter (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (Rs cr)
Net Sales - Quarterly
Lowest at Rs 72.94 cr
in the last five quartersMOJO Watch
Near term sales trend is negative
Net Sales (Rs Cr)
Interest - Quarterly
Highest at Rs 1.90 cr
in the last five quarters and Increased by 33.80 % (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (Rs cr)
